Paragonix Technologies specializes in advanced organ preservation technology, which is crucial for the safe transportation of donor organs at optimal temperatures. Their innovative devices, such as the Paragonix SherpaPak® Cardiac Transport System, LUNGguard®, and LIVERguard®, are designed to maintain a consistent thermal environment, preventing donor organs from being exposed to freezing temperatures. These systems are equipped with digital monitoring capabilities that allow transplant teams to track real-time temperature and GPS location, ensuring the integrity of the organ during transit. Additionally, Paragonix offers 24/7 clinical support services tailored to the specific needs of transplant centers, enhancing the overall efficiency and safety of organ procurement missions.

The company is also committed to extensive clinical research, exemplified by the GUARDIAN Registries, which serve as a comprehensive observational database to study the impact of organ preservation on post-transplant outcomes. With over 35 clinical studies published, Paragonix aims to provide valuable insights that can improve transplantation practices and patient outcomes. Their focus on data-driven solutions and real-world evidence underscores their dedication to advancing the standard of care in organ transplantation, ultimately benefiting both transplant recipients and healthcare providers.

United States

Paragonix Technologies is a rapidly growing medical device manufacturer that designs, manufactures, and sells organ transplant transport devices. Our dynamic team is committed to improving the lives of transplant patients by providing advanced technologies to ensure optimal preservation for donor organs on the journey to their ultimate recipients. Our primary offices are located in Waltham, MA.

Paragonix Technologies

Company Details